CAV1 and breast cancer: Examples of metabolic cooperation between CAFs and tumor cells that can alter endocrine responsiveness include the loss of stromal caveolin-1 (Cav-1), a predictive marker of poor clinical outcome in breast cancer patients treated with tamoxifen (68).